mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.3 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.055 |
0.3 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.3 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.3 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |